Neupulse - Discreet, Wrist-Worn Medical Device
Neupulse is a discreet, wrist-worn medical device designed to help reduce the frequency and intensity of motor and vocal tics in people with Tourette Syndrome. Backed by clinical research and developed with leading neuroscientists, Neupulse gives you a way to manage tics on your terms - anytime, anywhere.
- Apply the gel pads to the Neupulse device.
- Attach the Neupulse device securely using the adjustable strap.
- Switch on the Neupulse device and configure the stimulation to an effective level via the companion app.
- Wear during daily activities.
- Replace gel pad daily for best results.
It’s that simple - supporting you discreetly while you go about your day.
- Device type: Class IIa medical device
- Wearing position: right wrist
- Stimulation modes: Multiple intensity levels, user-controlled
- Power: Rechargeable battery (USB-C)
- Battery life: 8 hours on a full charge
- Materials: Medical-grade silicone and skin-safe components
- Connectivity: Bluetooth-enabled (iOS & Android compatible app)
- In the box: Neupulse device, USB-C charging cable, starter pack of gel pads, user manual
- Made in the UK
Once your device is delivered and your subscription begins you will have access to:
- Device & app support and updates - stay ahead with the latest features and improvements
- Two-year warranty - peace of mind with repair or replacement cover (only valid with a current subscription)
- 1-on-1 video consultations - access to product expert guidance tailored to your needs
- Exclusive member community - connect, share, and learn from others
- Custom-made gel pads - keep your device performing at its best without the hassle of reordering, and free of charge flex your deliveries based on usage
This device should not be used:
- By people with an implanted electrical medical device, such as a pacemaker, defibrillator, deep brain stimulator
- By people using body worn medical devices (e.g., insulin pumps cardiac monitors)
- With metallic implants in the lower arm, wrist or hand
- By people that have suspected or diagnosed epilepsy or other seizure disorder
- During pregnancy
- On swollen, infected, inflamed areas of skin, open wounds or cancerous lesions
- If there is impaired sensory awareness in the arm and/or hand
- On any other part of the body other than the underside of the right hand wrist
- By children under the age of 12 years old
- By people with a brain tumour
- By people with any implanted electrical device
- Do not use Neupulse if you are pregnant
Because Neupulse is a medical device, we have to make sure we do things the right way. We know the science, we have the data, and we are currently going through the process of gaining CA regulatory approval. This gives us and the community the confidence that we are not only providing a device that works, but one that meets the highest standards possible.
We also understand that these things take a long time. We wanted to give the community a clear indication that we are closer than ever to delivering the device and to give you the opportunity to be involved from the start. Whilst it is unfortunately only available in Great Britain at the moment, this is just the beginning. There will be plenty more to come from us as we approach our release date in 2026.
Neupulse helps reduce the intensity and frequency of tics, giving you more control throughout your day. Designed to fit seamlessly into your routine, it’s discreet, comfortable, and clinically backed - so you can feel more like you.
Motor Tics
77% of participants who received active stimulation experienced a reduction in motor tic severity of at least 25% compared to baseline after 4 weeks of daily stimulation
Phonic Tics
54% of participants who received active stimulation experienced a reduction in phonic tic severity of at least 25% compared to baseline after 4 weeks of daily stimulation
Instant Impact
The reduction in tic severity was immediate once participants started receiving stimulation
Long Term Benefit
After using the device for 4 weeks, people who received active stimulation experienced a reduction in their tic severity of more than 35%
We know from the Tourette Syndrome community that there has always been a strong desire for a solution that doesn`t involve drugs or involve major surgery. Neupulse delivers on this wish.
Delivery and support
Once available we`ll deliver the device to your home and provide full support from the moment you receive it.
The device is supported by our exclusive Neutrack app. Once available you will be able to download it from the Apple and Android App stores.
The device works differently for everyone, but the data shows an overwhelming majority feel the benefits of Neupulse immediately.
Neupulse is a breakthrough in neuroscience. A wearable device designed to gently rebalance brain activity, helping people with Tourette’s take control of their tics and their lives.
Drug free & non-invasive
Treatment should never take away your identity. Neupulse provides relief with no loss of cognitive functionality or side effects.
You`re in control
Support that fits into your life, not the other way around. The Neupulse device provides on-demand relief, whenever you choose.
Rooted in science
Neupulse is built on decades of research and clinical trials, transforming breakthrough neuroscience into a wearable solution for everyday life.
Our research has been guided by the voices of people with tic disorders and their families, who told us they wanted a safe, non-drug treatment that could be used outside the clinic and put individuals back in control of their tics. This feedback led us to explore peripheral nerve stimulation as a way to target the brain networks involved in tic production.
Through our studies, we found that gentle, rhythmic electrical stimulation of the median nerve at the wrist can strengthen brain rhythms linked to movement suppression. This approach has been shown to significantly reduce both tic frequency and the urge to tic, without affecting intentional movements or cognitive functions like attention.
Our research into Tourette syndrome began in 2005, with early work exploring cognitive control over tics and brain network function. Using advanced brain imaging and stimulation techniques, we investigated how neuroplastic changes in brain structure, function, and chemistry might explain why tics remit in some individuals. A key collaboration with the UK charity Tourettes Action in 2009 highlighted the urgent need for safe, effective, non-drug therapies that could be used outside of clinical settings, shaping the direction of our future studies.
From this, we explored non-invasive brain stimulation methods that could modulate brain oscillations linked to movement suppression. While approaches such as transcranial magnetic stimulation showed promise, they were not practical for everyday or child-friendly use. This challenge led us to study rhythmic peripheral nerve stimulation as an alternative, supported by funding from the University of Nottingham, Tourettes Action, and the NIHR Nottingham Biomedical Research Centre. These efforts culminated in the development of a novel therapeutic approach that now underpins our work at Neupulse.
A pivotal UK-wide double-blind clinical trial confirmed the potential of this therapy, showing that participants using active stimulation at home experienced a substantial reduction in tic severity and frequency. These results mark a breakthrough in creating a practical, safe, and effective non-drug treatment that individuals can administer independently. At Neupulse, we are building on this foundation, working to transform clinical research into a widely accessible medical device that redefines the therapeutic landscape for Tourette syndrome.